Finnish study on the efforts to prevent epilepsy in the last 40 Years
This 2015 Finnish study aimed to determine whether progress has been made in the prevention of epilepsy in Finland during the last 40 years.
This 2015 Finnish study aimed to determine whether progress has been made in the prevention of epilepsy in Finland during the last 40 years.
Summary Findings from First National Audit of Neurology Services in Ireland.
On International Epilepsy Day today, the HSE's Chief Information Officer, Richard Corbridge will announce details of the HSE's new Epilepsy Lighthouse Project. The announcement will be made at Epilepsy Ireland's Epilepsy Research Explained event this evening at the RCSI in Dublin.
Epilepsy Ireland and Headway have joined forces today to launch an innovative new public awareness campaign called I See Beyond (#iseebeyond). The campaign focuses on raising awareness of hidden disabilities like epilepsy and acquired brain injury and the challenges these conditions can present in day to day life.
Epilepsy Ireland and Headway have joined forces to raise awareness of hidden disabilities. The I See Beyond campaign will be launched on Wednesday February 3rd by the Minister for Health, Leo Varadkar.
An online brain training technique that increases alertness but calms the brain is showing promising results in helping people with epilepsy to control their seizures.
Scientists have discovered a new cause for the development of temporal lobe epilepsy.
The Danish Epilepsy Center in Copenhagen, has led an international research project, designed to study the current practices in European EMUs (Epilepsy Monitoring Units), with importance given to patient safety issues (SAEs).
A new Canadian study has documented the frequency, types and risk factors for injuries caused by seizures for people with childhood onset epilepsy.
Epilepsy Ireland is to partner with the Royal College of Surgeons and the Irish Research Council in supporting a new project investigating potential biomarkers that determine people's responsiveness to the epilepsy drug Levetiracetam (Keppra).